IDIX Financial Facts
Net loss: -30.75MLoss from operations: -31.02M
See Full Income Statement
Total liabilities and stockholders' equity (deficit): 226.49M
Deferred revenue, related party: 714K
See Full Balance Sheet
Earnings History for Idenix Pharmaceuticals Inc. (IDIX)
|
Expand Research on IDIX
| Next EPS Date | 5/21/13 *Est. | EPS Growth Rate | +5.6% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +27.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.5% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/25/13 | Q412 | -$0.17 | -$0.17 | $0.00 | $327K | $740K | N/A / N/A | N/A | -5% | Details | |
11/1/12  |
 |
Q312 | $0.03 | -$0.17 | +$0.20 | $32.3M | $2.6M | N/A / N/A | N/A | +19% | Details |
| 2/23/12 |
|
Q411 | -$0.18 | -$0.14 | -$0.04 | N/A | $3.07M | N/A / N/A | N/A | -66.1% | Details |
| 11/2/11 |
|
Q311 | -$0.12 | -$0.15 | +$0.03 | $2.64M | $2.56M | N/A / N/A | N/A | -32.3% | Details |
| 8/8/11 |
|
Q211 | -$0.15 | -$0.13 | -$0.02 | $1M | $2.45M | N/A / N/A | N/A | -19.9% | Details |
| 4/27/11 | Q111 | -$0.11 | -$0.15 | +$0.04 | $4M | $2.67M | N/A / N/A | N/A | -12.7% | Details | |
| 2/28/11 |
|
Q410 | -$0.22 | -$0.18 | -$0.04 | $24M | $6.05M | N/A / N/A | N/A | +24% | Details |
